COMPASS Pathways plc (CMPS) Stock Ticker
CMPS right now
Market factors today
Unlock the full CMPS picture
About COMPASS Pathways plc
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
CMPS stock facts
| Ticker symbol | CMPS |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.8B |
| CEO | Kabir Kumar Nath |
| Employees | 156 |
| Headquarters | London, CH, GB |
| IPO date | 2020-09-18 |
| Website | compasspathways.com |
What you can see for CMPS on Tickr
Live CMPS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CMPS report.
Rankings
FAQ
What is the ticker symbol for COMPASS Pathways plc?
The ticker symbol for COMPASS Pathways plc is CMPS, listed on the NASDAQ Global Select.
What is CMPS?
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is…